Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Notices 16149 

5630 Fishers Lane, rm. 1093), Rockville, 

MD 20857, 301–827–7001, FAX: 301– 

827–6776, e-mail: 

minh.doan@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512530. Please call the Information 

Line for up-to-date information on this 

meeting. A notice in the Federal 

Register about last minute modifications 

that impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the agency’s Web 

site and call the appropriate advisory 

committee hot line/phone line to learn 

about possible modifications before 

coming to the meeting. 

Agenda: On April 29, 2010, the 

committee will discuss the efficacy and 

safety of new drug application (NDA) 

21–242, artesunate rectal suppositories, 

submitted by the World Health 

Organization, for the proposed use as a 

single dose for the initial treatment of 

patients with acute malaria who cannot 

take medication by mouth and for 

whom injectable treatment is not 

available. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ 

AdvisoryCommittees/Calendar/ 

default.htm. Scroll down to the 

appropriate advisory committee link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before April 15, 2010. Oral 

presentations from the public will be 

scheduled between approximately 1 

p.m. to 2 p.m. Those desiring to make 

formal oral presentations should notify 

the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before April 7, 2010. Time allotted for 

each presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by April 8, 2010. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Minh Doan 

at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/ 

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: March 25, 2010. 

Jill Hartzler Warner, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2010–7113 Filed 3–30–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice Of Amendment—OS ARRA 

Expansion of Research Capabilities To 

Study CE Complex Patients (R24) SEP 

Meeting 

With this correction notice, the 

Agency for Healthcare Research and 

Quality (AHRQ) informs the public of 

an amendment made to the notice 

subject mentioned above published on 

March 18, 2010 Vol. 75, No. 52, Second 

paragraph of pages 13 135–13136. 

The revised should read: ‘‘DATE: 

April 15–16, 2010 (Open on April 15 

from 8 a.m. to 8:15 am. and closed for 

the remainder of the meeting)’’. 

Dated: March 19, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–6784 Filed 3–30–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–2312–N] 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

Medicaid and CHIP Programs; Meeting 

of the CHIP Working Group—April 26, 

2010 

AGENCIES: Centers for Medicare & 

Medicaid Services (CMS), Department 

of Health and Human Services (DHHS); 

Employee Benefits Security 

Administration (EBSA), Department of 

Labor (DOL). 

ACTION: Notice. 

SUMMARY: This notice announces the 

first meeting of the Medicaid, Children’s 

Health Insurance Program (‘‘CHIP’’), and 

Employer-Sponsored Coverage 

Coordination Working Group (referred 

to as the ‘‘CHIP Working Group’’). The 

CHIP Working Group will meet to 

address objectives specified under 

section 311(b)(1)(C) of the Children’s 

Health Insurance Program 

Reauthorization Act of 2009. This 

meeting is open to the public. 

DATES: Meeting Date: Monday, April 26, 

2010 from 9 a.m. to 5 p.m., Eastern 

Standard Time (E.S.T.). 

Deadline for Registration without Oral 

Presentation: April 21, 2010, 12 p.m., 

E.S.T. 

Deadline for Registration of Oral 

Presentations: April 12, 2010 12 p.m., 

E.S.T. 

Deadline for Submission of Oral 

Remarks and Written Comments: April 

12, 2010 12 p.m., E.S.T. 

Deadline for Requesting Special 

Accommodations: April 12, 2010 12 

p.m., E.S.T. 

ADDRESSES: Meeting Location: The 

meeting will be held at the Omni 

Shoreham, 2500 Calvert Street, NW. at 

Connecticut Avenue in Washington, DC 

20008. 

Submission of Testimony: 

Testimonies should be mailed to Stacey 

Green, Designated Federal Official 

(DFO), Centers for Medicare & Medicaid 

Services, 7500 Security Boulevard, Mail 

stop C2–04–04, Baltimore, MD 21244– 

1850, or contact the DFO via e-mail at 

stacey.green@cms.hhs.gov. 

FOR FURTHER INFORMATION CONTACT: 

Stacey Green, DFO, Centers for 

Medicare & Medicaid Services, DHHS at 

(410) 786–6102, or Amy Turner, 


jlentini on DSKJ8SOYB1PROD with NOTICES
16150 Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Notices 

Employee Benefits Security 

Administration, DOL at (202) 693–8335. 

News media representatives must 

contact the CMS Press Office, (202) 690– 

6145. Please refer to the Internet at 

http://www.cms.hhs.gov/FACA, or 

http://www.dol.gov/ebsa/CHIP.html for 

additional information and updates on 

committee activities. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In accordance with section 10(a) of 

the Federal Advisory Committee Act 

(FACA), this notice announces the first 

meeting of the Medicaid, CHIP, and 

Employer-Sponsored Coverage 

Coordination Working Group (‘‘CHIP 

Working Group’’). The Secretary of 

Health and Human Services and the 

Secretary of Labor are required under 

section 311(b)(1)(C) of the Children’s 

Health Insurance Program 

Reauthorization Act (CHIPRA) of 2009 

(Pub. L. 111–3), enacted February 4, 

2009, to jointly establish a CHIP 

Working Group. The membership of the 

group is based on nominations 

submitted in response to a Federal 

Register solicitation notice published on 

May 1, 2009 (74 FR 20323). The CHIP 

Working Group will meet two times to 

develop a model coverage coordination 

disclosure form for group health plan 

administrators to send to States upon 

request regarding benefits available 

under the plan. This notice will enable 

States to determine the availability and 

cost-effectiveness of providing premium 

assistance to individuals eligible for 

benefits under titles XIX or XXI of the 

Social Security Act (the Act) to enable 

them to enroll in group health plans. 

The CHIP Working Group will identify 

and report on the impediments to the 

effective coordination of coverage 

available to families that include 

employees of employers that maintain 

group health plans and members who 

are eligible for medical assistance under 

title XIX of the Act or child health 

assistance or other health benefits 

coverage under title XXI of the Act. 

Not later than August 5, 2010, the 

CHIP Working Group must submit to the 

Secretary of Labor and the Secretary of 

Health and Human Services the model 

coverage coordination disclosure form 

and the report containing 

recommendations for appropriate 

measures for addressing the 

impediments to the effective 

coordination of coverage. 

The CHIP Working Group consists of 

22 individuals, including 2 Co-Chairs. 

Members of the CHIP Working Group 

are composed of representatives of the 

Department of Labor (DOL); the 

Department of Health and Human 

Services (DHHS); State directors of the 

Medicaid Program under title XIX of the 

Act; State directors of the State 

Children’s Health Insurance Program 

under title XXI of the Act; employers, 

including owners of small businesses 

and their trade or industry 

representatives and certified human 

resource and payroll professionals; plan 

administrators and plan sponsors of 

group health plans as defined in section 

607(1) of the Employee Retirement 

Income Security Act of 1974, as 

amended; health insurance issuers; and 

representatives of children and other 

beneficiaries of medical assistance 

under title XIX of the Act or child 

health assistance or other health 

benefits coverage under title XXI of the 

Act. Members serve for the duration of 

the committee. 

The current members are: 

• Department of Labor: Phyllis Borzi; 

• Department of HHS: Victoria 

Wachino; 

• State Representatives, including 

Medicaid and CHIP Directors: Mari 

Spaulding-Bynon, Rhonda Medows, 

Howard ‘‘Rocky’’ King, Ann Clemency 

Kohler; Janet Olszewski, Linda 

Sheppard, and Anita Smith; 

• Employers, Plan Sponsors, and Plan 

Administrators: Emma BennettWilliams, Barbara Caress, Roberta 

Casper Watson, Greta Cowart, Kaye 

Pestaina, and Mark Stember; 

• Health Insurance Issuers: Terry 

Bayer, Ellyn Fuchsteiner, and Kevin 

Hayden; and 

• Representatives of Children and 

Other Beneficiaries of Medical 

Assistance: Joan Alker, George Askew, 

Miguel Carranza, and Karen Pollitz. 

II. Meeting Format and Agenda 

The meeting will commence with 

welcoming remarks for the CHIP 

Working Group by Departmental 

representatives. In addition, the agenda 

will focus on the following: 

• Opening statements from the CoChairs, as well as introductions and 

remarks by other CHIP Working Group 

members; 

• Swearing in of members; 

• An overview of FACA 

requirements; 

• An overview by DOL and HHS staff 

of the deliverables that the CHIP 

Working Group is responsible for under 

CHIPRA: 

+ A model coverage coordination 

disclosure form for plan administrators 

of group health plans. 

+ A report containing 

recommendations for appropriate 

measures for addressing the 

impediments to the effective 

coordination of coverage between group 

health plans and title XIX and XXI State 

plans. 

• An opportunity for public comment 

and testimony. 

For additional information and 

clarification on these topics, contact the 

DFO as provided in the FOR FURTHER

INFORMATION CONTACT section of this 

notice. Individual or organizational 

stakeholders that represent the focus 

area of the CHIP Working Group 

wishing to present a 5–minute oral 

testimony on agenda issues must 

register with the DFO by the date listed 

in the DATES section of this notice. 

Testimony is limited to agenda topics 

only. The number of oral testimonies 

may be limited by the time available. A 

written copy of the presenter’s oral 

remarks must be submitted to the DFO 

for distribution to CHIP Working Group 

members for review before the meeting 

by the date listed in the DATES section 

of this notice. Individual and 

organizational stakeholders not 

scheduled to speak may also submit 

written comments to the DFO for 

distribution by the date listed in the 

DATES section of this notice. 

III. Meeting Registration and Security 

Information 

The meeting is open to the public, but 

attendance is limited to the space 

available. Persons wishing to attend this 

meeting must register by contacting the 

DFO at the address listed in the 

ADDRESSES section of this notice or by 

telephone at the number listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by the date 

specified in the DATES section of this 

notice. 

Individuals requiring sign language 

interpretation or other special 

accommodations must contact the DFO 

via the contact information specified in 

the FOR FURTHER INFORMATION CONTACT

section of this notice by the date listed 

in the DATES section of this notice. 

Authority: Section 1868 of the Social 

Security Act (42 U.S.C. 1395ee) and section 

10(a) of Pub. L. 92–463 (5 U.S.C. App. 2, 

section 10(a)). 

Dated: March 25, 2010. 

Charlene Frizzera, 

Acting Administrator, Centers for Medicare 

& Medicaid Services. 

Dated: March 23, 2010. 

Michael L. Davis, 

Deputy Assistant Secretary, Employee 

Benefits Security Administration, Department 

of Labor. 

[FR Doc. 2010–7225 Filed 3–29–10; 8:45 am] 

BILLING CODE 4120–01–P; 4510–29–P 


jlentini on DSKJ8SOYB1PROD with NOTICES